The future of critical care
is high-precision automation
Adaptive to each individual patient
Automatically implementing goals set by the clinician
Repeatably, economically, at scale
Introducing the Admetsys clinical robotics system
For blood analysis and metabolic control
In critical care and surgery
Clinical automation controller
Real-time continuous blood diagnostics
Controlling glucose in critical care settings is medically essential, sustaining the body's ability to defend against acute complications and effectively heal. This is a vital factor for 80% of critical care patients, regardless any prior diagnosis of diabetes. Similarly, early detection of sepsis, for which lactate is a key diagnostic indicator, is pivotal to survivability. The combined impact of these is substantial:
|Glucose control||34%||1.8 days||$9,900|
|Sepsis mitigation||30%||2.3 days||$7,400|
Metabolic parameters such as glucose and lactate can change rapidly in critical care patients. Seeing variability accurately in real time is crucial. This requires:
This combination is precarious, since frequent blood draws often lead to hospital-acquired anemia, which requires transfusion.
To date, the standard of care for blood chemistry analysis and glucose control has been entirely manual. The clinical team draws blood, measures its chemistry using a lab analyzer or handheld instrument, calculates an insulin dose, and adjusts an infusion pump to administer the therapy. The clinical burden of this is significant and occurs in the context of shortages in skilled clinical personnel and escalating demand:
This process limits the standard of care, the number of patients who may be cared for, or both.
Everything thus far has been a compromise out of necessity. High-precision automation changes this equation.
Admetsys has conducted 3 clinical trials in the United States with outstanding outcomes:
|∗ 80–125 mg/dL||∗ 70–180 mg/dL|